Definium Therapeutics, Inc. · NASDAQ:DFTX
Krebs Andreas exercised options for 1,629 Definium Therapeutics, Inc. shares (Form 4)
Traded Sep 18, 2026 · Filed Sep 18, 2026
On Sep 18, 2026, Krebs Andreas (Director) exercised options for 1,629 Definium Therapeutics, Inc. shares at US$35.52 for US$57,862, leaving 21,402 shares. Filed Sep 18, 2026 (Form 4).
- Options exercised
- 1,629 shares
- Price
- US$35.52
- Value
- US$57,862
- Holding after
- 21,402 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Shares | Option exercise | 1,629 | US$35.52 | 21,402 | Direct |
Source
Related
- Definium Therapeutics, Inc.
- Krebs Andreas
- Definium Therapeutics, Inc. shareholders
- Form 4 · Krebs Andreas · Jun 15, 2026
- Form 4 · Karlin Daniel · Sep 29, 2026
- Form 4 · Barrow Robert · Sep 29, 2026
- Form 4 · Wiley Matthew T. · Sep 29, 2026
- Form 4 · Sullivan Mark · Sep 29, 2026
- Form 4 · Roberts Brandi · Sep 29, 2026